Genygi Life Sciences
Private Limited

Oncology

Abiragen-250

Packed:	250 mg / 120 Tablets
Manufacturer:	Hetero Labs Limited
Active ingredient:	Abirateron

Abiragen (active ingredient: Abiraterone) is a pharmaceutical drug used for the treatment of oncological diseases.

It is an antitumor agent prescribed for the treatment of prostate cancer.

Download Documentation

Reviews (0)

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Abiragen-250”

Disclaimer:

This medical information is intended exclusively for healthcare professionals in India. The products discussed herein may have different labeling and regulatory requirements in other countries.

The information provided on this site is scientific, evidence-based, and intended to address unsolicited medical inquiries in a balanced manner.

For full Prescribing Information, including indications, contraindications, warnings, precautions, and potential adverse events, please submit a medical information request.

This content is not intended as medical advice. Responsibility for patient care rests solely with the healthcare professional, based on their professional license, expertise, and knowledge of the patient.

This website does not engage in the sale or purchase of any medicines.

Abiragen-250

Reviews

Enzalutagen-40

Imatigen-100

Imatigen-400

Sorafgen-200

Sunitigen-25

Sunitigen-50

Tamoxigen-20

Genygi Life Sciences Private Limited

Abiragen-250

Reviews

Related products

Enzalutagen-40

Imatigen-100

Imatigen-400

Sorafgen-200

Sunitigen-25

Sunitigen-50

Tamoxigen-20

Genygi Life Sciences Private Limited